MDMA Encourages Predictability, Transparency at Meeting on 510(k) Process

MDMA members discussed the importance of a predictable and transparent 510(k) this week at a public forum held by FDA.  The meeting was conducted in order to discuss the ongoing evolution of the 510(k) approval process.  MDMA members' comments also focused on ways the FDA could demonstration how proposed changes will improve patient care and promote innovation.